Results from medical cannabis trials in Georgia show early promise

Georgia-based clinical trials have shown early promise in using cannabis oil to treat epileptic seizures, although researchers said they won’t know for sure until at least the end of next year what strides they have made in the study of medical marijuana.

The update came Wednesday during the latest meeting of the state’s Commission on Medical Cannabis, formed earlier this year to study the effect of Georgia’s new medical marijuana law and whether it should be expanded to allow growers to harvest and distribute cannabis oil in-state.

Dr. Yong Park, a neurologist leading the trials through Georgia Regents University’s Medical College of Georgia, said as of April, seizures caused by one of the most severe forms of epilepsy — Dravet syndrome — fell by as much as 60 percent in children who had used a specific drug, the cannabis-derived oil Epidiolex, for at least 12 weeks.

Seizures were also down...

Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.